Pages that link to "Q33785313"
Jump to navigation
Jump to search
The following pages link to Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials (Q33785313):
Displaying 50 items.
- Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials (Q21144611) (← links)
- Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Q22241288) (← links)
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary (Q22241786) (← links)
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association (Q26798326) (← links)
- Cardiovascular effects of basal insulins (Q26800249) (← links)
- Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence? (Q26827760) (← links)
- Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapies (Q26866958) (← links)
- Cellular and molecular mechanisms of metformin: an overview (Q27013561) (← links)
- Diagnosing and managing diabetes in HIV-infected patients: current concepts (Q27014697) (← links)
- Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination (Q27026211) (← links)
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. (Q27687851) (← links)
- Metformin as a cellular protector; a synoptic view of modern evidences (Q28817196) (← links)
- Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data (Q30530802) (← links)
- Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk (Q31053398) (← links)
- The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study (Q31138001) (← links)
- Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study (Q33754815) (← links)
- MARCH2: comparative assessment of therapeutic effects of acarbose and metformin in newly diagnosed type 2 diabetes patients (Q34078741) (← links)
- Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes (Q34684420) (← links)
- Cardiovascular safety profile of currently available diabetic drugs (Q34971736) (← links)
- Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review. (Q35042647) (← links)
- Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs (Q35535310) (← links)
- Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database (Q35780117) (← links)
- Five-year change of clinical and complications profile of diabetic patients under primary care: a population-based longitudinal study on 127,977 diabetic patients (Q36071201) (← links)
- Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients (Q36144000) (← links)
- Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review (Q36240156) (← links)
- Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span (Q36406255) (← links)
- Insulin therapy and cancer in type 2 diabetes (Q36417868) (← links)
- Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats (Q36422434) (← links)
- Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial (Q36633074) (← links)
- Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial (Q37277912) (← links)
- Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney (Q37366972) (← links)
- Is glucose control important for prevention of cardiovascular disease in diabetes? (Q37577137) (← links)
- Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes (Q37620904) (← links)
- Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users. (Q37673171) (← links)
- On the potential of acarbose to reduce cardiovascular disease (Q37717838) (← links)
- Optimal management of type 2 diabetes: the evidence (Q37961236) (← links)
- Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus (Q37961846) (← links)
- Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment (Q37982112) (← links)
- Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings (Q38014516) (← links)
- Individualized treatment of type 2 diabetes mellitus using noninsulin agents: clinical considerations for the primary care physician (Q38036773) (← links)
- Combine and conquer: advantages and disadvantages of fixed-dose combination therapy (Q38046641) (← links)
- Coronary heart disease in type 2 diabetes: mechanisms and comprehensive prevention strategies (Q38048842) (← links)
- Linagliptin plus metformin: a pharmacokinetic and pharmacodynamic evaluation (Q38078436) (← links)
- Efficacy and safety of Jentadueto® (linagliptin plus metformin). (Q38082848) (← links)
- Metformin therapy in diabetes: the role of cardioprotection (Q38083008) (← links)
- Treating the obese diabetic. (Q38087696) (← links)
- Incretin-based therapies: focus on effects beyond glycemic control alone (Q38140803) (← links)
- Complications of diabetes therapy. (Q38167147) (← links)
- Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus (Q38184608) (← links)
- Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia (Q38234927) (← links)